Anticorps Polyclonal de lapin anti-P21
P21 Polyclonal Antibody for IF, WB, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
rat, souris et plus (2)
Applications
WB, IHC, IF, ELISA
Conjugaison
Non conjugué
N° de cat : 27296-1-AP
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules Neuro-2a, cellules C6, cellules NIH/3T3 |
Résultats positifs en IF | cellules MCF-7, |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:500-1:1000 |
Immunofluorescence (IF) | IF : 1:200-1:800 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
WB | See 20 publications below |
IHC | See 1 publications below |
IF | See 5 publications below |
Informations sur le produit
27296-1-AP cible P21 dans les applications de WB, IHC, IF, ELISA et montre une réactivité avec des échantillons rat, souris
Réactivité | rat, souris |
Réactivité citée | rat, canin, Humain, souris |
Hôte / Isotype | Lapin / IgG |
Clonalité | Polyclonal |
Type | Anticorps |
Immunogène | P21 Protéine recombinante Ag26129 |
Nom complet | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
Masse moléculaire calculée | 18 kDa |
Poids moléculaire observé | 21 kDa |
Numéro d’acquisition GenBank | BC000275 |
Symbole du gène | CDKN1A |
Identification du gène (NCBI) | 1026 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par affinité contre l'antigène |
Tampon de stockage | PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
CDKN1A (p21, CIP1, WAF1) is a cyclin-dependent kinase inhibitor. CDKN1A binds to and inhibits the activity of cyclin-CDK2 or -CDK4 complexes, and thus functions as a regulator of cell cycle progression at the G1 phase. The expression of CDKN1A is induced by wild-type but not mutant p53 protein, through which CDKN1A mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. CDKN1A can interact with proliferating cell nuclear antigen (PCNA), and plays a regulatory role in S phase DNA replication and DNA damage repair. CDKN1A was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of CDK2, and may be instrumental in the execution of apoptosis following caspase activation. Two alternatively spliced variants, which encode an identical protein, have been reported.
Protocole
Product Specific Protocols | |
---|---|
WB protocol for P21 antibody 27296-1-AP | Download protocol |
IF protocol for P21 antibody 27296-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Am J Respir Crit Care Med CD38 Mediates Lung Fibrosis by Promoting Alveolar Epithelial Cell Aging | ||
J Clin Invest Circular RNA circEsyt2 regulates vascular smooth muscle cell remodeling via splicing regulation. | ||
Biomaterials MSC-derived exosomes protect against oxidative stress-induced skin injury via adaptive regulation of the NRF2 defense system. | ||
Cell Mol Life Sci Silencing circSERPINE2 restrains mesenchymal stem cell senescence via the YBX3/PCNA/p21 axis | ||
Oxid Med Cell Longev PIN1 Protects Hair Cells and Auditory HEI-OC1 Cells against Senescence by Inhibiting the PI3K/Akt/mTOR Pathway. | ||
Front Cell Dev Biol P53 independent pathogenic mechanisms contribute to BubR1 microcephaly |